173 related articles for article (PubMed ID: 15292065)
1. Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance.
Seré KM; Rosing J; Hackeng TM
Blood; 2004 Dec; 104(12):3624-30. PubMed ID: 15292065
[TBL] [Abstract][Full Text] [Related]
2. Alpha 2-macroglobulin enhances prothrombin activation and thrombin potential by inhibiting the anticoagulant protein C/protein S system in cord and adult plasma.
Cvirn G; Gallistl S; Koestenberger M; Kutschera J; Leschnik B; Muntean W
Thromb Res; 2002 Mar; 105(5):433-9. PubMed ID: 12062545
[TBL] [Abstract][Full Text] [Related]
3. Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children.
Noubouossie DF; Lê PQ; Corazza F; Debaugnies F; Rozen L; Ferster A; Demulder A
Am J Hematol; 2012 Feb; 87(2):145-9. PubMed ID: 22052675
[TBL] [Abstract][Full Text] [Related]
4. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma.
Elisen MG; von dem Borne PA; Bouma BN; Meijers JC
Blood; 1998 Mar; 91(5):1542-7. PubMed ID: 9473218
[TBL] [Abstract][Full Text] [Related]
5. Phospholipid-bound tissue factor modulates both thrombin generation and APC-mediated factor Va inactivation.
Váradi K; Siekmann J; Turecek PL; Schwarz HP; Marder VJ
Thromb Haemost; 1999 Dec; 82(6):1673-9. PubMed ID: 10613654
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation.
Koshiar RL; Somajo S; Norström E; Dahlbäck B
PLoS One; 2014; 9(8):e104200. PubMed ID: 25136857
[TBL] [Abstract][Full Text] [Related]
7. Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells.
Ravanat C; Archipoff G; Beretz A; Freund G; Cazenave JP; Freyssinet JM
Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):7-13. PubMed ID: 1311563
[TBL] [Abstract][Full Text] [Related]
8. Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC-resistant individuals.
Nicolaes GA; Thomassen MC; Tans G; Rosing J; Hemker HC
Blood Coagul Fibrinolysis; 1997 Jan; 8(1):28-38. PubMed ID: 9105635
[TBL] [Abstract][Full Text] [Related]
9. Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis.
Tripodi A; Primignani M; Lemma L; Chantarangkul V; Mannucci PM
J Hepatol; 2013 Aug; 59(2):265-70. PubMed ID: 23583273
[TBL] [Abstract][Full Text] [Related]
10. Activated protein C accelerates clot lysis by virtue of its anticoagulant activity.
de Fouw NJ; van Tilburg NH; Haverkate F; Bertina RM
Blood Coagul Fibrinolysis; 1993 Apr; 4(2):201-10. PubMed ID: 8388739
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral contraceptives on the anticoagulant activity of protein S in plasma.
Koenen RR; Christella M; Thomassen LG; Tans G; Rosing J; Hackeng TM
Thromb Haemost; 2005 May; 93(5):853-9. PubMed ID: 15886799
[TBL] [Abstract][Full Text] [Related]
12. The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies.
Membre A; Wahl D; Latger-Cannard V; Max JP; Lacolley P; Lecompte T; Regnault V
Haematologica; 2008 Apr; 93(4):566-73. PubMed ID: 18322249
[TBL] [Abstract][Full Text] [Related]
13. Gly74Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function.
Chen C; Yang L; Villoutreix BO; Wang X; Ding Q; Rezaie AR
Thromb Haemost; 2017 Jun; 117(7):1358-1369. PubMed ID: 28405673
[TBL] [Abstract][Full Text] [Related]
14. Activated protein C-dependent and -independent anticoagulant activities of protein S have different structural requirements.
Heeb MJ; Griffin JH
Blood Cells Mol Dis; 2002; 29(2):190-9. PubMed ID: 12490286
[TBL] [Abstract][Full Text] [Related]
15. Detection of procoagulant imbalance. Modified endogenous thrombin potential with results expressed as ratio of values with-to-without thrombomodulin.
Tripodi A
Thromb Haemost; 2017 May; 117(5):830-836. PubMed ID: 28229158
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms that regulate the anticoagulant function of coagulation factor V.
Thorelli E
Scand J Clin Lab Invest Suppl; 1999; 229():19-26. PubMed ID: 10097286
[TBL] [Abstract][Full Text] [Related]
17. Effects of (pre-)analytical variables on activated protein C resistance determined via a thrombin generation-based assay.
Curvers J; Christella M; Thomassen LG; de Ronde H; Bertina RM; Rosendaal FR; Tans G; Rosing J
Thromb Haemost; 2002 Mar; 87(3):483-92. PubMed ID: 11924538
[TBL] [Abstract][Full Text] [Related]
18. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
[TBL] [Abstract][Full Text] [Related]
19. The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution.
De Smedt E; Wagenvoord R; Coen Hemker H
Thromb Haemost; 2009 Jan; 101(1):165-70. PubMed ID: 19132204
[TBL] [Abstract][Full Text] [Related]
20. The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis.
Mosnier LO; Meijers JC; Bouma BN
Thromb Haemost; 2001 Oct; 86(4):1040-6. PubMed ID: 11686322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
